Pr François Ghiringhelli
- Spécialité
- Oncologue médical, expert digestif
- Hôpital
- Centre Georges-François Leclerc (Dijon)
- Derniers articles
-
- MORPHEUS-Lung: biomarkers and clinical response to atezolizumab + bevacizumab + stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer. (16 avr. 2027)
- Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts. (31 déc. 2026)
- Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors. (1 mai 2026)
- Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity. (22 avr. 2026)
- Early-Onset Metastatic Colorectal Adenocarcinoma Incidence and Survival Among Patients Younger Than 50 Years. (1 avr. 2026)